ML Schubert, M Schmitt, L Wang… - Annals of oncology …, 2021 - pubmed.ncbi.nlm.nih.gov
Chimeric antigen receptor (CAR) T cells directed against the B-cell marker CD19 are currently changing the landscape for treatment of patients with refractory and/or relapsed B …
ML Schubert, M Schmitt, L Wang… - Annals of Oncology …, 2020 - europepmc.org
Chimeric antigen receptor (CAR) T cells directed against the B-cell marker CD19 are currently changing the landscape for treatment of patients with refractory and/or relapsed B …
ML Schubert, M Schmitt, L Wang… - Annals of …, 2021 - annalsofoncology.org
Chimeric antigen receptor (CAR) T cells directed against the B-cell marker CD19 are currently changing the landscape for treatment of patients with refractory and/or relapsed B …